Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (go test finale): study protocol of a multicentre pragmatic randomized superiority trial

HIGHLIGHTS

• who: Iris Rose Peeters from the The study started on , February , and is currently recruiting patients in seven participating centres in the Netherlands (all rheumatology departments): Sint Maartenskliniek (Nijmegen, Geldrop, Boxmeer and Woerden), VieCuri Medical Centre, Bravis hospital, Bernhoven hospital, Erasmus Medical Centre, Maastricht University Medical Centre, Medisch Spectrum Twente, Ziekenhuisgroep Twente and Martini hospitalAdditionally, three centres (Radboudumc, Rijnstate hospital and hospital Gelderse Vallei) refer eligible patients to the Sint Maartenskliniek Nijmegen. Patients have published the Article: Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.